|
|
|
ISPOR Ninth ANNUAL INTERNATIONAL MEETING AWARDS RECIPIENTS |
by Stephen L. Priori, Director, ISPOR
Publications
During the ISPOR Ninth Annual International Meeting, the scientific merit
exhibited in contributed poster and podium presentations was recognized with
Contributed Paper Award in the following categories: Overall, students and
new investigators. This year, the ISPOR Awards Committee evaluated
approximately 48 podium presentations and over 550 poster presentations.
Evaluations of scientific merit were based upon the following criteria:
• Background provides appropriate perspective / context for the subject
• Objectives / research questions are clearly stated
• Research design / methods / modeling is appropriate and transparent
(scores on this will determine winners in case of ties)
• Data sources and/or sampling procedures are clear and appropriate
• Data analyses are appropriate
• Research objectives are met/addressed
• Implications of findings are discussed
• Factual information is kept separate from interpretations or implications
• Abstract is presented in an unbiased manner
• Clarity of presentation
A SPECIAL THANKS GOES TO Les Noe RPh, MPA, Chair, ISPOR Contributed
Research Paper Awards Task Force -- Poster Presentations AND HIS COMMITTEE,
AS WELL AS TO Ya-Chen Tina Shih MS, PhD, Chair, ISPOR Contributed
Research Paper Awards Task Force -- Podium Presentations AND HER COMMITTEE,
FOR ALL THEIR EFFORTS IN SELECTING THE WINNERS
And the recipients are...
BEST CONTRIBUTED PAPER
AWARDS PODIUM PRESENTATIONS
HM4
HOW ROBUST IS COST-EFFECTIVENESS RATIO TO MISSING DATA IMPUTATION? ANALYSIS
OF LONG-TERM CLINICAL TRIAL IN PARKINSONS DISEASE
Noyes K, Holloway RG, Dick AW
University of Rochester School of Medicine, Rochester, NY, USA
PE1
ASSESSING EFFECTIVENESS IN THE PRESENCE OF TREATMENT SWITCHING: DATA FROM AN
EFFECTIVENESS STUDY OF ANTIPSYCHOTICS
Faries D1, Nyhuis A1, Tunis SL1, Hernan M2
1Eli Lilly and Company, Indianapolis, IN, USA; 2Harvard School of Public
Health, Boston, MA, USA
RI3
COST-EFFECTIVENESS OF INFLUENZA VACCINE IN 6-24 MONTH OLD CHILDREN
Woolcott JC1, Marra F1, Brunham RC2
1BC Centre for Disease Control, Vancouver, BC, Canada; 2University of
British Columbia Centre for Disease Control, Vancouver, BC, Canada
BEST NEW INVESTIGATOR
PODIUM PRESENTATION
CV1
HEALTH PREFERENCES AFTER CABG OR PCI FOLLOWING AN ACUTE MYOCARDIAL
INFARCTION
Radeva J, Reed S, Weinfurt K, Anstrom K, Velazquez E, Schulman K
Duke Clinical Research Institute, Durham, NC, USA
HP1
EVALUATION OF GENERIC DISPENSING INCENTIVE PROGRAM (GDIP)
Hong SH
University of Arkansas for Medical Sciences, Little Rock, AR, USA
MH4
ASSESSMENT OF HEALTH STATE UTILITIES FOR ATTENTION-DEFICIT/HYPERACTIVITY
DISORDER IN CHILDREN USING PARENT-BASED STANDARD GAMBLE SCORES
Secnik K1, Cottrell S2, Matza L3, Edgell E4, Aristides M5, Tilden D2,
Burridge J5, Mannix S6
1Eli Lilly and Company, Indianapolis, IN, USA; 2M-TAG Pty Ltd., London,
England; 3MEDTAP International, Bethesda, MD, USA; 4Lilly Research Centre,
Windlesham, United Kingdom; 5M-TAG Limited, London, United Kingdom; 6MEDTAP
International, Inc, Bethesda, MD, USA
BEST STUDENT PODIUM
PRESENTATION
AC3
COMPARISION OF ADHERENCE TO ANTIHYPERTENSIVES IN A MANAGED CARE POPULATION.
Naik RK1, Borrego ME1, Gupchup GV1, D'Angio R2, Sabrsula S3
1University of New Mexico, Albuquerque, NM, USA; 2Pfizer Inc,
Albuquerque, NM, USA; 3Firstcare MCO, Albuquerque, NM, USA
OP2
COMPARISON OF DISCRETE CHOICE EXPERIMENT (DCE) WITH VISUAL ANALOG SCALING
(VAS) METHODS FOR ESTIMATING PREFERENCES FOR PHYSICAL DISABILITY STATES
Banks JL1, Netten A2, Ryan M3, Watson V4, Salas M5
1University of Kent at Canterbury, Lincoln, MA, USA; 2University of Kent at
Canterbury, Canterbury, Kent, United Kingdom; 3University of Aberdeen,
Aberdeen, United Kingdom; 4University of Aberdeen Medical School, Aberdeen,
United Kingdom; 5Erasmus University Medical School, Rotterdam, Netherlands
SC4E
ECONOMIC EVALUATION OF SCREENING FOR THE A-ADDUCIN GENE VARIANT IN
HYPERTENSIVE PATIENTS
Meckley LM, Veenstra DL
University of Washington, Seattle, WA, USA
BEST CONTRIBUTED PAPER AWARDS
POSTER PRESENTATIONS
PAR18
RACIAL DISPARITIES IN PRESCRIBING OF SELECTIVE CYCLOOXYGENASE-2 INHIBITORS
OVER OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS IN A MEDICAID MANAGED CARE
POPULATION
Shaya FT, Blume SW, Blanchette CM, Mullins CD
University of Maryland, Baltimore, MD, USA
PCV47
THE NATIONAL ANTICOAGULATION BENCHMARK AND OUTCOMES REPORT (NABOR™):
EVIDENCE OF A SIGNIFICANT DIFFERENCE BETWEEN GUIDELINES AND ACTUAL PRACTICE
Shillington A1, Tapson V2, Hyers T3, Becker R2, Colgan K1
1EPI-Q, Inc, Oakbrook Terrace, IL, USA; 2Duke University Medical Center,
Durham, NC, USA; 3CARE Clinical Research, St. Louis, MO, USA
PHP34
EXPLICIT INDICATORS TO MEASURE PREVENTABLE DRUG-RELATED MORBIDITY IN AN
ELDERLY POPULATION
Faris RJ
University of Tennessee, Memphis, TN, USA
BEST NEW INVESTIGATOR
POSTER PRESENTATION
PCV42
PERSISTENCE AND ADHERENCE TO STATIN THERAPY IN A MANAGED CARE SETTING
Quach C1, Nichol MB2, Chen L1, Patel BV1, Berenbeim D1
1MedImpact Health care Systems Inc, San Diego, CA, USA; 2University of
Southern California, Los Angeles, CA, USA
PCV51
RETROSPECTIVE EVALUATION OF UTILIZATION PATTERNS OF BETA-BLOCKER THERAPY IN
CONGESTIVE HEART FAILURE PATIENTS IN A MANAGED CARE ENVIRONMENT
Thaker DJ, Godley PJ, Browne BA, Rohack J, Houck P
Scott & White, Temple, TX, USA
PIN1
OUTCOMES OF AN INTERACTIVE VOICE RESPONSE (IVR) REMINDER SYSTEM TO PROMOTE
MANAGED CARE ORGANIZATION (MCO) MEMBERS' ATTAINMENT OF INFLUENZA
IMMUNIZATION
Sikirica V1, Crawford A1, Goldfarb N1, Nash D1, Popiel R2, Patel M2, Wang
C2, Chu J2
1Department of Health Policy, Jefferson Medical College, Philadelphia, PA,
USA; 2Horizon Blue Cross Blue Shield of New Jersey, Newark, NJ, USA
BEST STUDENT POSTER
PRESENTATION
PAR7
ASSESSMENT OF PATIENT-REPORTED OUTCOMES AMONG OSTEOARTHRITIC PATIENTS
Gandra SR, Lawrence LW
The University of Louisiana at Monroe, Monroe, LA, USA
PCN20
PRELIMINARY ECONOMIC ANALYSIS OF THE AMERICAN CANCER SOCIETY GUIDELINES FOR
MAMMOGRAPHY SCREENING IN AVERAGE-RISK WOMEN UNDER 70 YEARS OF AGE
Zammit D, Hay J
University of Southern California, Los Angeles, CA, USA
PMD15
RELIABILITY AND VALIDITY OF THE EQ-5D SELF-REPORT QUESTIONNAIRE IN TAIWAN
POPULATION
Chang TJ, Tarn YH
National Defense Medical Center, Taipei, Taiwan
ISPOR WOULD LIKE TO THANK ALL THE JUDGES WHO HAVE
VOLUNTEERED THEIR TIME AND EFFORTS DURING THE MEETING TO SCORE PODIUM AND
POSTER PRESENTATIONS
ISPOR SERVICE AWARDEES
ISPOR 2003 – 2004 BOARD OF DIRECTORS SERVICE AWARDS
PAST PRESIDENT (2002-2003) Peter Davey MD, FRCP, Head of
Pharmacoeconomics, University of Dundee, Dept. of Clinical Pharmacology,
Ninewells Hospital & Medical School, Dundee DD1 9SY, Scotland
DIRECTOR (2002-2004) Kerstin (Chris) Bingefors MSc, PhD, Associate
Professor, Research Director, Biomedical Centre, Uppsala University, Dept of
Pharmacy; Pharmacoepidemiology & PE, Box 580, Uppsala S-75123, Sweden
DIRECTOR (2002-2004) D.S. (Pete) Fullerton PhD, Professor
(Affiliate), University of Washington, 4910 Purdue Ave NE, Seattle,
Washington 98105
DIRECTOR (2002-2004) Mark Nuijten PhD, MD, MBA, Director of European
Business Development, MEDTAP International, Molenpad 4 Jisp 1546 CL, The
Netherlands
TREASURER (2001-2004) Jean Paul Gagnon PhD, Director, Public Policy,
Aventis Pharmaceuticals Inc., 300 Somerset Corporate Ctr, SC3-720A,
Bridgewater, NJ 08807
ISPOR DISTINGUISHED
SERVICE AWARDS
NINTH ANNUAL INTERNATIONAL MEETING PROGRAM CHAIR
Bernie O'Brien PhD, BA, MSc, Professor, Dept. of Clinical Epidemiology &
Biostatistics, Director of The Program for Assessment of Technology in
Health (P.A.T.H.), 25 Main Street W., Suite 2000, Hamilton, ON L8P 1H1
Canada
HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS CO-EDITORS
Kerstin (Chris) Bingefors MSc, PhD, Associate Professor, Uppsala
University, Dept of Pharmacy, Pharmacoepidemiology & PE, Biomedical Center,
Box 580, Uppsala S-75123, Sweden
Marc Berger MD, Vice President, Outcomes Research & Management, Merck
& Company, Inc., PO Box 4, WP39-162, South Broad Street and Sumneytown Pike,
West Point, PA 19486-0004
Edwin Hedblom PharmD, Global Health Economics Manager, Medical
Division. 3M, 3M Corporate Center, Bldg 275-4W-02, St. Paul, MN 55133
Chris Pashos PhD, Vice President & Executive Director of
Pharmacoeconomics & Outcomes Research
Abt Associates Clinical Trials, 55 Wheeler Street, Cambridge, MA 02138
George Torrance PhD, Vice President, McMaster University and Innovus
Research Inc., 1016-A Sutton Drive, Suite 200, Burlington, Ontario, Canada
L7L 6B8
Marilyn Dix Smith RPh, PhD, Executive Director, ISPOR, 3100 Princeton
Pike, Bldg 3, Suite D
Lawrenceville, NJ 08648
STUDENT NETWORK CHAIR
Ritesh Kumar B.S.Pharm, M.S., Doctoral Candidate, University of
Michigan, College of Pharmacy, 428 Church Street, Ann Arbor, MI 48109-1065
AUBURN UNIVERSITY - ISPOR STUDENT CHAPTER PRESIDENT
Nikhil Khandelwal BS Pharm., M.S., Doctoral Student
FLORIDA A&M UNIVERSITY - ISPOR STUDENT CHAPTER PRESIDENT
Benita D. Williams BS, Master’s Candidate
OHIO STATE UNIVERSITY - ISPOR STUDENT CHAPTER PRESIDENT
Spencer Harper PharmD
RUTGERS UNIVERSITY - ISPOR STUDENT CHAPTER PRESIDENT
Concetta Crivera PharmD, Master’s Candidate
UNIVERSITY OF ARIZONA - ISPOR STUDENT CHAPTER PRESIDENT
Durgesh D. Bhandary BSPharm, MS, Pre-Doctoral Fellow
UNIVERSITY OF FLORIDA - ISPOR STUDENT CHAPTER PRESIDENT
Dionne Mayhew MPH, Doctoral Student
UNIVERSITY OF HOUSTON - ISPOR STUDENT CHAPTER PRESIDENT
Monali Bhosle BS, Master’s Candidate
UNIVERSITY OF LOUISIANA AT MONROE - ISPOR STUDENT CHAPTER PRESIDENT
Larry Humble BS Pharm., Doctoral Student
UNIVERSITY OF MARYLAND - ISPOR STUDENT CHAPTER PRESIDENT
Prasun Subedi BS
UNIVERSITY OF MICHIGAN - ISPOR STUDENT CHAPTER PRESIDENT
Mathew C. Garber BS Pharm, PharmD, MA in economics, Doctoral Student
UNIVERSITY OF MINNESOTA - ISPOR STUDENT CHAPTER PRESIDENT
Shuchita Agarwal BS Pharm, MBA, Doctoral Candidate
UNIVERSITY OF NEW MEXICO - ISPOR STUDENT CHAPTER PRESIDENT
Rupali Naik BS Pharm, MBA, Master's Candidate
UNIVERSITY OF RHODE ISLAND - ISPOR STUDENT CHAPTER PRESIDENT
Greg Low BS Pharm, MS, Doctoral Student
UNIVERSITY OF SOUTH CAROLINA - ISPOR STUDENT CHAPTER PRESIDENT
Brian Meissner PharmD, Doctoral Student
UNIVERSITY OF SOUTHERN CALIFORNIA - ISPOR STUDENT CHAPTER PRESIDENT
Vaishali Patel PharmD, Master’s Candidate
UNIVERSITY OF TENNESSEE - ISPOR STUDENT CHAPTER PRESIDENT
Cameron James BA, PharmD, Doctoral student
UNIVERSITY OF TEXAS - ISPOR STUDENT CHAPTER PRESIDENT
Homa B. Dastani BS Pharm., MS, Doctoral Candidate
UNIVERSITY OF TOLEDO - ISPOR STUDENT CHAPTER PRESIDENT
Jason Lundy BA Economics and Political Science, Graduate Student
VIRGINIA COMMONWEALTH UNIVERSITY – CHAPTER PRESIDENT
Anuprita Patklar MS Pharm
UNIVERSITY OF TORONTO - ISPOR STUDENT CHAPTER PRESIDENT
Colin Vicente BSc (Hons), Master’s Candidate
WEST VIRGINIA UNIVERSITY - ISPOR STUDENT CHAPTER PRESIDENT
Ashish V. Joshi BS Pharm, MS, Pfizer Fellow/ Doctoral Candidate
UNIVERSITY OF DUNDEE - ISPOR STUDENT CHAPTER PRESIDENT
Benjamin D Ofori BS Pharm., MSc., MRPharmS, Doctoral Student/Research
Training Fellow
UNIVERSITY OF UTAH – CHAPTER PRESIDENT
Mei-Jen Ho PharmD
UNIVERSITY OF GEORGIA – CHAPTER PRESIDENT
Hua Chen MS
UNIVERSITY OF ILLINOIS AT CHICAGO- CHAPTER PRESIDENT
Hayley Park BSc, PharmD
Return to ISPOR Awards Index Page
|
|
